Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin
- PMID: 109460
- DOI: 10.1210/jcem-48-6-989
Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin
Abstract
TSH concentration was measured in plasma before and after TRH administration (200 micrograms, iv) in 89 patients with documented hypothyroidism consequent to various hypothalamic-pituitary disorders. Basal plasma TSH was less than 1.0 microI/ml in 34.8%, between 1.0-3.6 microU/ml in 40.5% and slightly elevated (3.7-9.7 microU/ml) in 24.7% of the cases. The plasma TSH response to TRH was absent in 13.5%, impaired in 16.8%, normal in 47.2%, and exaggerated in 22.5% of the cases, with delayed and/or prolonged pattern of response in 65% of the cases. The dilution curves of several plasmas drawn before and after TRH were parallel to those obtained with TSH standard preparation. After gel filtration, the elution pattern of TRH-stimulated plasmas from 4 patients did not show any major difference from that of pooled plasmas from normal subjects given TRH or from that of patients with primary hypothyroidism. Plasma TSH values determined by cytochemical bioassay on both basal and TRH-stimulated samples of 5 patients were markedly lower than those obtained by RIA. The serum T3 response to TRH was absent or low in 40 out of 53 patients in whom it was evaluated. The administration of T3 (100 micrograms/day for 3 days) or dexamethasone (3 mg/day for 5 days) respectively suppressed or reduced both basal and TRH-induced plasma TSH levels. Two patients became hypothyroid shortly after pituitary surgery in spite of basal and TRH-induced plasma TSH levels similar to or higher than those before surgery. Though thyroid atrophy due to chronic understimulation could explain the low T3 response to TRH in secondary hypothyroidism, it is difficult to reconcile thyroid understimulation with normal or increased plasma TSH unless the immunoreactive material has low biological activity. Present data suggest that several patients with hypothyroidism consequent to hypothalamic-pituitary diseases secrete a material which is immunologically similar to pituitary standard TSH and responds to stimulatory and suppressive agents in a manner similar to normal TSH but has low or absent biological activity. Thus, hypothyroidism due to insufficient TSH stimulation can be termed central hypothyroidism and can be due 1) to pituitary insufficiency (secondary hypothyroidism), 2) to a hypothalamic defect (tertiary hypothyroidism), or 3) to the secretion of biologically inactive TSH.
Similar articles
-
Central hypothyroidism--various types of TSH responses to TRH stimulation.Endocr Regul. 1994 Mar;28(1):35-40. Endocr Regul. 1994. PMID: 7949012
-
Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.J Clin Endocrinol Metab. 1990 May;70(5):1305-11. doi: 10.1210/jcem-70-5-1305. J Clin Endocrinol Metab. 1990. PMID: 2110573
-
Excess of beta-subunit of thyrotropin (TSH) in patients with idiopathic central hypothyroidism due to the secretion of TSH with reduced biological activity.J Clin Endocrinol Metab. 1983 May;56(5):908-14. doi: 10.1210/jcem-56-5-908. J Clin Endocrinol Metab. 1983. PMID: 6187763
-
TSH secretion and regulation in endemic goiter and endemic cretinism.Prog Clin Biol Res. 1983;116:119-30. Prog Clin Biol Res. 1983. PMID: 6304776 Review.
-
The clinical impact of the thyrotropin-releasing hormone test.Thyroid. 1998 Oct;8(10):903-8. doi: 10.1089/thy.1998.8.903. Thyroid. 1998. PMID: 9827657 Review.
Cited by
-
Exaggerated and prolonged thyrotrophin releasing hormone (TRH) test responses in tertiary hypothyroidism.J Clin Pathol. 1991 Jun;44(6):522-3. doi: 10.1136/jcp.44.6.522. J Clin Pathol. 1991. PMID: 1906072 Free PMC article.
-
The TRH test provides valuable information in the diagnosis of central hypothyroidism in patients with known pituitary disease and low T4 levels.Front Endocrinol (Lausanne). 2023 Oct 2;14:1226887. doi: 10.3389/fendo.2023.1226887. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37850100 Free PMC article.
-
Clinical use of sensitive assays for thyroid-stimulating hormone.J Gen Intern Med. 1996 Feb;11(2):115-27. doi: 10.1007/BF02599589. J Gen Intern Med. 1996. PMID: 8833021 Review.
-
Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4.J Endocrinol Invest. 1981 Oct-Dec;4(4):413-22. doi: 10.1007/BF03348305. J Endocrinol Invest. 1981. PMID: 6801107
-
Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin.J Endocrinol Invest. 1993 Jul-Aug;16(7):511-9. doi: 10.1007/BF03348894. J Endocrinol Invest. 1993. PMID: 8227980
MeSH terms
Substances
LinkOut - more resources
Full Text Sources